|
Avid Bioservices® was established as a wholly- owned subsidiary of Peregrine Pharmaceuticals in 2002. While we may appear relatively young, we have been manufacturing in our Tustin, California facilities since 1997, with much of our current manufacturing staff being here since that time. Avid provides highly specialized cell culture, process development and cGMP manufacturing services for the biotechnology and biopharmaceutical industries utilizing mammalian cell culture to support pre-clinical, Phase I, II, III and commercial production.
We can offer you a complete package beginning with cell line development, to process development, full-scale manufacturing, purification, and ultimately, filling in to vials or bulk packaging. We also are able to perform a full range of in- house analytical services, as well as offer regulatory support. You, as our valued customer, may request a complete program starting with cell line development through bulk packaging of your product or develop customized programs based on your specific requirements.
Our capabilities include:
- Process Development
- Cell line development and optimization
- Scale- up expertise:
- From 5L spinner flasks up to 100L SUB (single use bioreactor)
- Scale- down expertise
- Purification development
- Viral clearance studies
- cGMP Commercial & Clinical Biomanufacturing
- Dedicated mammalian cell culture facility
- 100L, 300L, 1000L Stirred tank bioreactors
- Perfusion, batch and fed- batch modes of operation
- Dedicated purification suites
- Fully Integrated Company
- Master & working Cell Banks
- Final formulation screening
- Final product filling:
- In vials or bulk
- Stability studies
- Analytical Support
- Characterization testing
- Related Purities testing
- Content/ Identification testing
- Safety assays
- Custom assay development
- CMC development
- Document preparation
- Regulatory support
Safe Harbor Statement: This website may contain certain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Actual results may differ from the Company's expectations as a result of risk factors discussed in Peregrine Pharmaceuticals, Inc. reports on file with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's most recent periodic reports on Form 10-K and 10-Q, and any prospectus describing the Company's securities. Avid Bioservices, Inc. is a wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc.
|
